Bioqual Stock-Based Compensation 2010-2025 | BIOQ

Bioqual stock-based compensation from 2010 to 2025. Stock-based compensation can be defined as the estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors
Bioqual Annual Stock-Based Compensation
(Millions of US $)
2024 $N/A
2023 $N/A
2022 $0
2021 $0
2020 $0
2019 $0
2018 $0
2017 $N/A
2016 $N/A
2015 $N/A
2013 $N/A
2012 $N/A
2011 $N/A
2010 $N/A
2009 $N/A
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.041B $0.059B
BIOQUAL, Inc., formerly Diagnon Corporation, develops, produces and sells diagnostic test kits incorporating monoclonal antibodies to diagnose certain anemias, infections, and parasitic diseases.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $19.255B 18.98
Encompass Health (EHC) United States $12.022B 25.49
DaVita (DVA) United States $10.562B 14.85
Chemed (CHE) United States $8.098B 25.45
Elanco Animal Health (ELAN) United States $6.397B 13.70
Option Care Health (OPCH) United States $5.206B 23.20
RadNet (RDNT) United States $4.527B 287.33
Amedisys (AMED) United States $3.100B 20.85
LifeStance Health (LFST) United States $2.232B 0.00
Addus HomeCare (ADUS) United States $1.992B 21.87
Astrana Health (ASTH) United States $1.486B 36.81
U.S Physical Therapy (USPH) United States $1.174B 30.29
Aveanna Healthcare Holdings (AVAH) United States $1.135B 64.67
Pennant (PNTG) United States $1.010B 37.10
Atai Life Sciences (ATAI) Germany $0.286B 0.00
Daxor (DXR) United States $0.035B 0.00
Ontrak (OTRK) United States $0.007B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.005B 0.00
Psychemedics (PMD) United States $0.000B 0.00